Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Why would a patient trust a peptide more than a statin? STAT FDA takes first step in possible reversal of ban on some peptides The Washington Post